Indego Exoskeleton After SCI

August 28, 2018 updated by: Parker Hannifin Corporation

Impact of Gait Training With an Exoskeleton on Walking Function After Spinal Cord Injury (SCI)

The purpose of this study is to assess the use of Indego as a gait training tool for subjects with complete or incomplete paraplegia as a result of spinal cord injury (SCI) who have preserved lower extremity function. It is hypothesized that subjects with complete or incomplete paraplegia who have preserved their lower extremity function will experience functional improvements after gait training with the Indego exoskeleton.

Subjects will complete a total of fifteen (15) sessions which include a combination of the following; Physical Therapy Evaluation, Indego Training, Mid-Way Assessment, and Post-Assessment.

The aim of this study is to measure the impact of gait training with the Indego device on body structure, function, and participation. Additionally it will assess the perceptions of physical therapists and subjects with SCI on the effectiveness of gait training with the Indego exoskeleton in subjects with preserved limited function.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

9

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Port Jefferson, New York, United States
        • St. Charles Hospital
    • Texas
      • Houston, Texas, United States, - TIRR Memorial Hermann,
        • TIRR Memorial Hermann
    • Virginia
      • Mechanicsville, Virginia, United States, 23116
        • Sheltering Arms

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years or older
  • Height 5'1" to 6'3" (Acceptable height may vary by a few inches depending on femur length)
  • Weight 250 lbs or less
  • Present with paraplegia resulting from a complete or incomplete (AIS A, B, C, or D) Spinal Cord Injury (>1 year post-injury), with preserved LE function
  • Uses wheelchair as primary means of mobility in the community
  • Able to ambulate 14 meters with assist of 2 people and no orthostasis. Subjects may use any combination of stability aids and/or bracing.
  • Medical clearance for weight bearing and locomotor training

    • Bone density exams will be at the discretion of each sites' Principle Investigator
  • Passive range of motion (PROM) at shoulders, trunk, hips, knees and ankles within functional limits for safe gait and use of appropriate assistive device/stability aid
  • Skin intact where interfaces with the Indego device
  • Modified Ashworth Scale 3 or less in bilateral LEs
  • Blood pressure and heart rate within Locomotor Training Guidelines

    • At rest: Systolic 150 or less Diastolic 90 or less and Heart rate 105 or less
    • Exercise: Systolic 180 or less Diastolic 105 or less and Heart Rate 145 or less

Exclusion Criteria:

  • Inability to meet ALL inclusion criteria
  • Currently participating in physical therapy for gait training
  • Joint contractures of the shoulders, trunk, hips knees or ankles deemed unsafe for locomotor training by PT and or MD
  • Edema that would put skin at risk for breakdown
  • Modified Ashworth Spasticity of 4
  • Inability to achieve adequate fit of the Indego device
  • Pregnancy
  • Colostomy bag

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SCI Patients
  • 10 subjects with complete or incomplete SCI (> 1 year post-injury) with preserved LE function will be recruited.
  • No control group
Subjects who have Spinal Cord Injury will wear the Indego device which will include being trained and evaluated for fifteen (15) sessions.
Other Names:
  • Vanderbilt exoskeleton

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional ambulation category (FAC) to measure gait quality
Time Frame: 1 Day
Categorizes patients according to basic motor skills necessary for functional ambulation
1 Day
10 Meter Walking Test to measure fast gait speed
Time Frame: 1 Day
Assesses walking speed in meters per second over a short duration
1 Day
6 Minute Walking test to measure endurance
Time Frame: 6 Minutes
Measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface
6 Minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2016

Primary Completion (Actual)

March 1, 2018

Study Completion (Actual)

March 1, 2018

Study Registration Dates

First Submitted

May 24, 2016

First Submitted That Met QC Criteria

June 2, 2016

First Posted (Estimate)

June 8, 2016

Study Record Updates

Last Update Posted (Actual)

August 31, 2018

Last Update Submitted That Met QC Criteria

August 28, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injury

Clinical Trials on Indego Powered Exoskeleton

Subscribe